1-4 of 4
S Tucker
Close
Sort by
Journal Articles

Patients with IgM Monoclonal Gammopathy of Undetermined Significance (MGUS) or IgA with an M Band < 1.0 g/DL Have the Same Low Risk of Progression to Lymphoplasmacytic Neoplasm (LPN) As Those with IgG MGUS and an M-Band < 1.5 g/DL

Ashok P Pai, Lue-Yen S Tucker, David M. Baer
Journal: Blood
Blood (2022) 140 (Supplement 1): 4374–4375.
https://doi.org/10.1182/blood-2022-170758
Published: 2022
Journal Articles

A Phase II Trial of Ofatumumab for Older Patients and Patients Who Refuse Fludarabine-Based Regimens with Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma,

Ian W. Flinn, MD, PhD, William N. Harwin, MD, Inés M. Macias-Pérez, PhD, Patrick S. Tucker, MS, David M. Waterhouse, MD, Steven W. Papish, MD, Jeffrey A. Jones, MD, MPH, John D. Hainsworth, MD, John C. Byrd, MD
Journal: Blood
Blood (2011) 118 (21): 3912.
https://doi.org/10.1182/blood.V118.21.3912.3912
Published: 2011
Journal Articles

Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)

WS Velasquez, F Cabanillas, P Salvador, P McLaughlin, M Fridrik, S Tucker, S Jagannath, FB Hagemeister, JR Redman, F Swan
Journal: Blood
Blood (1988) 71 (1): 117–122.
https://doi.org/10.1182/blood.V71.1.117.117
Published: 1988
Journal Articles

Evaluation of drugs for elimination of leukemic cells from the bone marrow of patients with acute leukemia

ML Auber, LJ Horwitz, A Blaauw, S Khorana, S Tucker, T Woods, M Warmuth, KA Dicke, KB McCredie, G Spitzer
Journal: Blood
Blood (1988) 71 (1): 166–172.
https://doi.org/10.1182/blood.V71.1.166.166
Published: 1988